Big Tech’s eMudhra fixes may leave crypto bots exposed, CertiK warns
CertiK says crypto trading bots and exchange applications may remain exposed to the eMudhra certificate flaw because browser fixes may not protect all software.
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
CertiK says crypto trading bots and exchange applications may remain exposed to the eMudhra certificate flaw because browser fixes may not protect all software.
Truist reiterates Buy on Intuitive Surgical stock, $510 target
Wall Street’s Big Three have generated $52 billion in equity trading revenue this year, capturing about 80% of the market on rising margin lending to hedge funds.
Piper Sandler cuts Align Technology stock price target on volume decline
Piper Sandler reiterates Neutral rating on SpaceX stock at $140
Japan booked a trade deficit of $17.8 billion (2.82 trillion Japanese yen) for April to September, almost double the deficit from a year earlier, government data showed on Wednesday, as the Middle East crisis made energy imports into the resource-poor G7 economy much more expensive. Between April and September, the period right after the Iran war began and choked oil and LNG supply at the Strait…
Hardware wallets aren’t the only way to protect your crypto, but from ETFs and passkeys to multisig accounts, each alternative has its own risks and trade-offs.
Unicycive stock jumps as FDA accepts OLC drug resubmission
Is AT&T stock a buy-the-dip opportunity after its earnings-led selloff?
Buy the dip in Netflix stock as Q3 results show “no new negatives”: DB
Why is HSBC stock climbing today?
Oppenheimer Lists Top Industrial Efficiency Stocks Into Q3 Earnings
Nigeria says private capital to drive next growth phase, petrol subsidy gone
Oxford Metrics director acquires shares worth £10,000
Earnings call transcript: Basic-Fit Q3 2026 growth stays strong as shares slip
Top insider buys and sells disclosed on Tuesday
Earnings call transcript: Deutsche Börse tops Q3 2026 forecasts, raises outlook
Stifel reiterates Buy rating on LB Pharmaceuticals stock at $53
Stifel reiterates Buy on Valmont Industries stock, $623 target
Philip Morris stock rating maintained at buy by Stifel on Q3 beat
News text belongs to its source; only the headline and a short summary appear here.